Conditions: Coronary Artery Disease Chronic Kidney Disease Hypovitaminosis D Secondary Hyperparathyroidism
Keywords: Vitamin D Coronary Artery Disease (CAD) Chronic Kidney Disease (CKD)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 10
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.

Detailed description:
Vitamin D deficiency is common and has been associated with an increased risk of heart disease. In patients with the combination of kidney disease and heart disease, inflammation is thought to contribute to a high rate of cardiac events. Less is known about the effects of vitamin D supplementation on certain tests associated with inflammation in the body.

Arms:
arm 1: oral paricalcitol 2 mcg daily arm 2: one oral placebo drug daily

Interventions: intervention 1: paricalcitol intervention 2: placebo
Intervention descriptions: intervention 1: 2 mcg oral paricalcitol daily intervention 2: placebo

Protocol document: